A citation-based method for searching scientific literature


List of co-cited articles
1068 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacogenetics in major depression: a comprehensive meta-analysis.
Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2013
135
26

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.
Stefano Porcelli, Chiara Fabbri, Alessandro Serretti. Eur Neuropsychopharmacol 2012
201
25

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
Francis J McMahon, Silvia Buervenich, Dennis Charney, Robert Lipsky, A John Rush, Alexander F Wilson, Alexa J M Sorant, George J Papanicolaou, Gonzalo Laje, Maurizio Fava,[...]. Am J Hum Genet 2006
322
15


Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
418
15



Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Hyeran Kim, Shinn-Won Lim, Seonwoo Kim, Jong-Won Kim, Yun Hee Chang, Bernard J Carroll, Doh Kwan Kim. JAMA 2006
149
12

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
12


Pharmacogenetics of antidepressant response.
Stefano Porcelli, Antonio Drago, Chiara Fabbri, Sara Gibiino, Raffaella Calati, Alessandro Serretti. J Psychiatry Neurosci 2011
104
11

Allelic variation of human serotonin transporter gene expression.
A Heils, A Teufel, S Petri, G Stöber, P Riederer, D Bengel, K P Lesch. J Neurochem 1996
11

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
274
11

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Rudolf Uher, Nader Perroud, Mandy Y M Ng, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery,[...]. Am J Psychiatry 2010
239
11

A genomewide association study of citalopram response in major depressive disorder.
Holly A Garriock, Jeffrey B Kraft, Stanley I Shyn, Eric J Peters, Jennifer S Yokoyama, Gregory D Jenkins, Megan S Reinalda, Susan L Slager, Patrick J McGrath, Steven P Hamilton. Biol Psychiatry 2010
214
11

Investigation of serotonin-related genes in antidepressant response.
E J Peters, S L Slager, P J McGrath, J A Knowles, S P Hamilton. Mol Psychiatry 2004
184
10

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
10

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
10

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
584
10

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Marcus Ising, Susanne Lucae, Elisabeth B Binder, Thomas Bettecken, Manfred Uhr, Stephan Ripke, Martin A Kohli, Johannes M Hennings, Sonja Horstmann, Stefan Kloiber,[...]. Arch Gen Psychiatry 2009
217
10

Contribution of common genetic variants to antidepressant response.
Katherine E Tansey, Michel Guipponi, Xiaolan Hu, Enrico Domenici, Glyn Lewis, Alain Malafosse, Jens R Wendland, Cathryn M Lewis, Peter McGuffin, Rudolf Uher. Biol Psychiatry 2013
117
10

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Xian-Zhang Hu, A John Rush, Dennis Charney, Alexander F Wilson, Alexa J M Sorant, George J Papanicolaou, Maurizio Fava, Madhukar H Trivedi, Stephen R Wisniewski, Gonzalo Laje,[...]. Arch Gen Psychiatry 2007
168
10

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Ari Illi, Eija Setälä-Soikkeli, Merja Viikki, Outi Poutanen, Heini Huhtala, Nina Mononen, Terho Lehtimäki, Esa Leinonen, Olli Kampman. Neuroreport 2009
93
9

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
Sonja Horstmann, Susanne Lucae, Andreas Menke, Johannes M Hennings, Marcus Ising, Darina Roeske, Bertram Müller-Myhsok, Florian Holsboer, Elisabeth B Binder. Neuropsychopharmacology 2010
113
9

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.
Avshalom Caspi, Karen Sugden, Terrie E Moffitt, Alan Taylor, Ian W Craig, HonaLee Harrington, Joseph McClay, Jonathan Mill, Judy Martin, Antony Braithwaite,[...]. Science 2003
9

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
Elisabeth B Binder, Daria Salyakina, Peter Lichtner, Gabriele M Wochnik, Marcus Ising, Benno Pütz, Sergi Papiol, Shaun Seaman, Susanne Lucae, Martin A Kohli,[...]. Nat Genet 2004
657
9

Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients.
Julia Staeker, Stefan Leucht, Barbara Laika, Werner Steimer. Genet Test Mol Biomarkers 2014
24
37

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
Masaki Kato, Tsuyoshi Fukuda, Masataka Wakeno, Kazuhiro Fukuda, Gaku Okugawa, Yuka Ikenaga, Megumi Yamashita, Yoshiteru Takekita, Kenji Nobuhara, Junichi Azuma,[...]. Neuropsychobiology 2006
118
9

Genetic predictors of response to antidepressants in the GENDEP project.
Rudolf Uher, Patricia Huezo-Diaz, Nader Perroud, Rebecca Smith, Marcella Rietschel, Ole Mors, Joanna Hauser, Wolfgang Maier, Dejan Kozel, Neven Henigsberg,[...]. Pharmacogenomics J 2009
152
8

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.
M J V Wilkie, G Smith, R K Day, K Matthews, D Smith, D Blackwood, I C Reid, C R Wolf. Pharmacogenomics J 2009
72
11

Moderation of antidepressant response by the serotonin transporter gene.
Patricia Huezo-Diaz, Rudolf Uher, Rebecca Smith, Marcella Rietschel, Neven Henigsberg, Andrej Marusic, Ole Mors, Wolfgang Maier, Joanna Hauser, Daniel Souery,[...]. Br J Psychiatry 2009
115
8

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
109
8

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
Manfred Uhr, Alina Tontsch, Christian Namendorf, Stephan Ripke, Susanne Lucae, Marcus Ising, Tatjana Dose, Martin Ebinger, Marcus Rosenhagen, Martin Kohli,[...]. Neuron 2008
243
8

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
Chiara Fabbri, Giulia Di Girolamo, Alessandro Serretti. Am J Med Genet B Neuropsychiatr Genet 2013
56
14

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
Silvia Paddock, Gonzalo Laje, Dennis Charney, A John Rush, Alexander F Wilson, Alexa J M Sorant, Robert Lipsky, Stephen R Wisniewski, Husseini Manji, Francis J McMahon. Am J Psychiatry 2007
151
8


Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Keizo Yoshida, Hitoshi Takahashi, Hisashi Higuchi, Mitsuhiro Kamata, Ken-ichi Ito, Kazuhiro Sato, Shingo Naito, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue,[...]. Am J Psychiatry 2004
130
7

Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis.
Xiaofeng Zhao, Yinglin Huang, Jingying Li, Hui Ma, Qiu Jin, Yuan Wang, Lijuan Wu, Gang Zhu. Int Clin Psychopharmacol 2012
16
43

HTR2A gene variation is involved in antidepressant treatment response.
Susanne Lucae, Marcus Ising, Sonja Horstmann, Bernhard T Baune, Volker Arolt, Bertram Müller-Myhsok, Florian Holsboer, Katharina Domschke. Eur Neuropsychopharmacol 2010
51
13

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Taro Kishi, Reiji Yoshimura, Tsuyoshi Kitajima, Tomo Okochi, Takenori Okumura, Tomoko Tsunoka, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Hiroshi Naitoh,[...]. Neuromolecular Med 2010
44
15

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.
K P Lesch, D Bengel, A Heils, S Z Sabol, B D Greenberg, S Petri, J Benjamin, C R Müller, D H Hamer, D L Murphy. Science 1996
7


The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.
Michael F Egan, Masami Kojima, Joseph H Callicott, Terry E Goldberg, Bhaskar S Kolachana, Alessandro Bertolino, Eugene Zaitsev, Bert Gold, David Goldman, Michael Dean,[...]. Cell 2003
7

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.
F W Lohoff, T D Aquino, S Narasimhan, P K Multani, B Etemad, K Rickels. Pharmacogenomics J 2013
30
23

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman, A Batzler, R B Altman, V Arolt, J Brockmöller, C H Chen,[...]. Transl Psychiatry 2015
68
10

ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.
Barbara Breitenstein, Tanja Maria Brückl, Marcus Ising, Bertram Müller-Myhsok, Florian Holsboer, Darina Czamara. Am J Med Genet B Neuropsychiatr Genet 2015
36
19


Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.
Xian-Zhang Hu, Robert H Lipsky, Guanshan Zhu, Longina A Akhtar, Julie Taubman, Benjamin D Greenberg, Ke Xu, Paul D Arnold, Margaret A Richter, James L Kennedy,[...]. Am J Hum Genet 2006
863
7


Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
270
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.